143.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$142.21
Aprire:
$142.47
Volume 24 ore:
893.96K
Relative Volume:
0.16
Capitalizzazione di mercato:
$229.80B
Reddito:
$61.50B
Utile/perdita netta:
$14.76B
Rapporto P/E:
16.22
EPS:
8.83
Flusso di cassa netto:
$-30.33B
1 W Prestazione:
+1.70%
1M Prestazione:
+5.45%
6M Prestazione:
+3.98%
1 anno Prestazione:
+40.53%
Morgan Stanley Stock (MS) Company Profile
Nome
Morgan Stanley
Settore
Industria
Telefono
212-761-4000
Indirizzo
1585 BROADWAY, NEW YORK, NY
Confronta MS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MS
Morgan Stanley
|
143.24 | 223.78B | 61.50B | 14.76B | -30.33B | 8.83 |
![]()
GS
Goldman Sachs Group Inc
|
724.33 | 214.91B | 56.21B | 15.56B | -24.50B | 45.38 |
![]()
SCHW
Charles Schwab Corp
|
95.62 | 173.32B | 21.63B | 7.28B | 9.79B | 3.72 |
![]()
HOOD
Robinhood Markets Inc
|
101.75 | 89.88B | 3.26B | 1.59B | 1.06B | 1.76 |
![]()
CRCL
Circle Internet Group Inc
|
192.04 | 45.14B | 1.07B | -739.23M | 65.03M | -3.9232 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-09 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
2024-11-26 | Downgrade | HSBC Securities | Buy → Hold |
2024-11-15 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2024-10-04 | Aggiornamento | HSBC Securities | Hold → Buy |
2024-09-11 | Downgrade | Goldman | Buy → Neutral |
2024-08-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
2024-07-17 | Downgrade | Oppenheimer | Outperform → Perform |
2024-01-17 | Downgrade | JP Morgan | Overweight → Neutral |
2024-01-17 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
2024-01-09 | Downgrade | HSBC Securities | Buy → Hold |
2023-11-28 | Downgrade | Societe Generale | Buy → Hold |
2023-11-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
2023-10-23 | Downgrade | Odeon | Buy → Hold |
2023-10-20 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
2023-10-11 | Downgrade | UBS | Buy → Neutral |
2023-09-07 | Iniziato | HSBC Securities | Buy |
2023-07-12 | Aggiornamento | Odeon | Hold → Buy |
2023-01-18 | Downgrade | Citigroup | Buy → Neutral |
2023-01-10 | Aggiornamento | Odeon | Sell → Hold |
2023-01-04 | Downgrade | Wolfe Research | Outperform → Underperform |
2022-10-05 | Downgrade | Atlantic Equities | Overweight → Neutral |
2022-09-06 | Downgrade | Odeon | Hold → Sell |
2022-05-03 | Aggiornamento | Oppenheimer | Perform → Outperform |
2022-01-28 | Downgrade | Odeon | Buy → Hold |
2021-12-03 | Aggiornamento | Citigroup | Neutral → Buy |
2021-10-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2021-10-04 | Reiterato | Jefferies | Buy |
2021-09-29 | Downgrade | Oppenheimer | Outperform → Perform |
2021-09-28 | Downgrade | Berenberg | Buy → Hold |
2021-08-13 | Downgrade | Seaport Global Securities | Buy → Neutral |
2021-07-07 | Ripresa | Keefe Bruyette | Outperform |
2021-06-09 | Iniziato | Jefferies | Buy |
2021-04-21 | Aggiornamento | Berenberg | Hold → Buy |
2021-03-02 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
2021-01-06 | Iniziato | Daiwa Securities | Neutral |
2021-01-04 | Aggiornamento | Barclays | Equal Weight → Overweight |
2020-11-10 | Downgrade | Citigroup | Buy → Neutral |
2020-10-13 | Ripresa | JP Morgan | Overweight |
2020-07-08 | Iniziato | Seaport Global Securities | Buy |
2020-06-24 | Aggiornamento | DA Davidson | Neutral → Buy |
2020-06-23 | Reiterato | UBS | Buy |
2020-05-21 | Aggiornamento | Odeon | Hold → Buy |
2020-04-14 | Aggiornamento | Societe Generale | Sell → Buy |
2020-03-13 | Aggiornamento | Goldman | Neutral → Buy |
2020-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
2020-02-21 | Downgrade | DA Davidson | Buy → Neutral |
2020-02-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-01-21 | Downgrade | Citigroup | Buy → Neutral |
2020-01-17 | Downgrade | Piper Sandler | Overweight → Neutral |
2020-01-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2020-01-09 | Iniziato | DA Davidson | Buy |
2020-01-06 | Downgrade | Deutsche Bank | Buy → Hold |
2019-10-29 | Downgrade | Odeon | Buy → Hold |
2019-10-10 | Aggiornamento | Sandler O'Neill | Hold → Buy |
2019-07-12 | Aggiornamento | Citigroup | Neutral → Buy |
2019-04-18 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Morgan Stanley Borsa (MS) Ultime notizie
Morgan Stanley lifts BASF rating to Overweight on ’number of catalysts ahead’ - Investing.com
Morgan Stanley's Sheets Warns of 'Different' 2H for Markets - MarketScreener
Alphabet price target raised to $210 from $205 at Morgan Stanley - TipRanks
GE Vernova price target raised to $675 from $511 at Morgan Stanley - TipRanks
Morgan Stanley Warns: Tariff Deadline Could Crash Your 401(K) Again - MSN
E*TRADE’s Power E*TRADE Pro Launch and Retail Surge Might Change The Case For Investing In MS - simplywall.st
SS&C price target raised to $88 from $75 at Morgan Stanley - TipRanks
Watch Morgan Stanley’s Sheets Sees ‘Different’ 2H for Markets - Bloomberg.com
BASF upgraded to Overweight from Equal Weight at Morgan Stanley - TipRanks
Morgan Stanley: Here's How Big Companies View Sustainability - Sustainability Magazine
Morgan Stanley Predicts S&P 500 Index Will Hit Massive New All-Time High by Mid-2026 – But There’s a Catch: Report - The Daily Hodl
Morgan Stanley under probe for wealth management client vetting issues – report - Private Banker International
Morgan Stanley Ceases Substantial Holding in Imdex Ltd - TipRanks
Dr. Reddy’s Shares Spike After Morgan Stanley, BofA Raises Price Target Post Q1 Results - NDTV Profit
Nvidia (NVDA) Named a Top Pick Ahead of Earnings, Says Morgan Stanley - MSN
Morgan Stanley stays bullish on US stocks (July 21) - MSN
Will the Entertainment Business Stay Human? - Morgan Stanley
Brunswick price target raised to $51 from $47 at Morgan Stanley - TipRanks
Synchrony price target raised to $72 from $70 at Morgan Stanley - TipRanks
Morgan Stanley Faces Probe Over Anti-Money Laundering Practices - PYMNTS.com
The Coast Is Not Clear on Tariffs - Morgan Stanley
The Vast Opportunities in AI - Morgan Stanley
NEWS: FINRA seeks Morgan Stanley’s org charts, reporting lines, risk scoring tools in major EDD probe; focus on PEPs - AML Intelligence
Report: Finra probing Morgan Stanley's money laundering controls - Citywire
Morgan Stanley's highest conviction picks into earnings - CNBC
Morgan Stanley stock rating downgraded to Hold by Freedom Broker - Investing.com
What drives Morgan Stanley Preferred Security stock priceBreakthrough investment results - Autocar Professional
Morgan Stanley Is Subject of Probe Into How It Vetted Clients, WSJ Reports - Barron's
Form 424B2 MORGAN STANLEY - StreetInsider
Morgan Stanley (MS) Under Scrutiny in Finra Money Laundering Probe - GuruFocus
Freedom Broker Downgrades Morgan Stanley (MS) to Hold - StreetInsider
Morgan Stanley Profit Jumps 17% in Q2 - The Motley Fool
Morgan Stanley Reveals Best Performing Humanoid Robot Stocks Since February - Wccftech
Morgan Stanley's vetting of wealth-management clients under investigationreport (MS:NYSE) - Seeking Alpha
Stock Movers: GoPro, Texas Instruments, Morgan Stanley - Bloomberg.com
Microsoft Stock: A GenAI Winner Poised for More Success, Says Morgan Stanley - TipRanks
Morgan Stanley (NYSE:MS) Shares Unloaded Rep. Julie Johnson - MarketBeat
Morgan Stanley maintains Freeport-McMoRan stock rating despite strong Q2 - Investing.com
Jim Cramer on Morgan Stanley’s Earnings: “Very Solid Set of Numbers” - Insider Monkey
India to Become 3rd-Largest Economy by 2028, Reach $10.6 Trillion by 2035: Morgan Stanley - INDIA New England News
Roundup: Trade deal with Japan / Morgan Stanley / AI drug research - Baton Rouge Business Report
Dempze Nancy E Sells 4,000 Shares of Morgan Stanley (NYSE:MS) - MarketBeat
12 Stocks Jim Cramer Discussed As Analyzed Morgan Stanley’s Comments - Insider Monkey
Morgan Stanley Reiterates Equalweight Rating on Freeport-McMoRan (FCX) - StreetInsider
Quest Diagnostics price target raised to $191 from $182 at Morgan Stanley - TipRanks
Morgan Stanley upgrades Abivax stock to Overweight on strong ulcerative colitis data - Investing.com
Morgan Stanley Facing Finra Probe on Client Vetting: WSJ - MarketScreener
Morgan Stanley Under Finra Scrutiny For Allegedly Flawed Vetting of Clients, Potential Money Laundering Risks: ReportMorgan Stanley (NYSE:MS) - Benzinga
RTX price target raised, named ‘Top Pick’ in Aerospace at Morgan Stanley - TipRanks
Morgan Stanley recommends buying the dip in Philip Morris International (PM:NYSE) - Seeking Alpha
Morgan Stanley Humanoid 100 list up 11.1% since inception, outperforming indices - Investing.com
Morgan Stanley Azioni (MS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):